344 related articles for article (PubMed ID: 11007921)
1. Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation.
Erickson-Miller CL; Pelus LM; Lord KA
Stem Cells; 2000; 18(5):366-73. PubMed ID: 11007921
[TBL] [Abstract][Full Text] [Related]
2. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.
Aguilar C; Aguilar C; Lopez-Marure R; Jiménez-Sánchez A; Rocha-Zavaleta L
Mol Med Rep; 2014 May; 9(5):1895-902. PubMed ID: 24626629
[TBL] [Abstract][Full Text] [Related]
3. Low doses of EPO activate MAP kinases but not JAK2-STAT5 in rat vascular smooth muscle cells.
Ammarguellat F; Llovera M; Kelly PA; Goffin V
Biochem Biophys Res Commun; 2001 Jun; 284(4):1031-8. PubMed ID: 11409898
[TBL] [Abstract][Full Text] [Related]
4. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
5. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
[TBL] [Abstract][Full Text] [Related]
6. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.
Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C
EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946
[TBL] [Abstract][Full Text] [Related]
8. Epo regulates erythroid proliferation and differentiation through distinct signaling pathways: implication for erythropoiesis and Friend virus-induced erythroleukemia.
Zochodne B; Truong AH; Stetler K; Higgins RR; Howard J; Dumont D; Berger SA; Ben-David Y
Oncogene; 2000 May; 19(19):2296-304. PubMed ID: 10822380
[TBL] [Abstract][Full Text] [Related]
9. A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis.
Wakao H; Chida D; Damen JE; Krystal G; Miyajima A
Biochem Biophys Res Commun; 1997 May; 234(1):198-205. PubMed ID: 9168989
[TBL] [Abstract][Full Text] [Related]
10. [Proliferative signal transmission mediated by EpoR in leukemic cell lines].
Fan H; Kanji S; Zhai M
Zhonghua Xue Ye Xue Za Zhi; 2000 Jun; 21(6):294-7. PubMed ID: 11876995
[TBL] [Abstract][Full Text] [Related]
11. Stem cell factor synergistically enhances thrombopoietin-induced STAT5 signaling in megakaryocyte progenitors through JAK2 and Src kinase.
Drayer AL; Boer AK; Los EL; Esselink MT; Vellenga E
Stem Cells; 2005 Feb; 23(2):240-51. PubMed ID: 15671147
[TBL] [Abstract][Full Text] [Related]
12. Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells.
Sakamoto H; Kitamura T; Yoshimura A
J Biol Chem; 2000 Nov; 275(46):35857-62. PubMed ID: 10960479
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2.
Kilic U; Kilic E; Soliz J; Bassetti CI; Gassmann M; Hermann DM
FASEB J; 2005 Feb; 19(2):249-51. PubMed ID: 15556972
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma.
Lai SY; Childs EE; Xi S; Coppelli FM; Gooding WE; Wells A; Ferris RL; Grandis JR
Oncogene; 2005 Jun; 24(27):4442-9. PubMed ID: 15856028
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin induces sustained phosphorylation of STAT5 in primitive but not definitive erythrocytes generated from mouse embryonic stem cells.
Tsuji-Takayama K; Otani T; Inoue T; Nakamura S; Motoda R; Kibata M; Orita K
Exp Hematol; 2006 Oct; 34(10):1323-32. PubMed ID: 16982325
[TBL] [Abstract][Full Text] [Related]
16. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
Tong W; Zhang J; Lodish HF
Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
[TBL] [Abstract][Full Text] [Related]
17. Differentiation inducers modulate cytokine signaling pathways in a murine erythroleukemia cell line.
Yamashita T; Wakao H; Miyajima A; Asano S
Cancer Res; 1998 Feb; 58(3):556-61. PubMed ID: 9458105
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5.
Okajima Y; Matsumura I; Nishiura T; Hashimoto K; Yoshida H; Ishikawa J; Wakao H; Yoshimura A; Kanakura Y; Tomiyama Y; Matsuzawa Y
J Biol Chem; 1998 Sep; 273(36):22877-83. PubMed ID: 9722506
[TBL] [Abstract][Full Text] [Related]
19. Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation.
Mui AL; Wakao H; Kinoshita T; Kitamura T; Miyajima A
EMBO J; 1996 May; 15(10):2425-33. PubMed ID: 8665850
[TBL] [Abstract][Full Text] [Related]
20. SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells.
Wu DW; Stark KC; Dunnington D; Dillon SB; Yi T; Jones C; Pelus LM
Blood Cells Mol Dis; 2000 Feb; 26(1):15-24. PubMed ID: 10772872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
